These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8718548)

  • 1. [Cytotoxic action of monoclonal antibodies OC125 and SH-9 on ovarian cancer cell lines].
    Murakami F
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Feb; 48(2):125-32. PubMed ID: 8718548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivities of mouse monoclonal antibody K2.7 to renal cancers in complement dependent cytotoxicity and antibody dependent cell-mediated cytotoxicity.
    Kinouchi T; Bander NH; Kotake T
    J Urol; 1995 Jul; 154(1):288-92. PubMed ID: 7776448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A new monoclonal antibody (SH-9) recognizes the low molecular mass of ovarian cancer antigen CA125].
    Maeda H; Imai S; Morimoto J; Kiyozuka Y; Noda T; Haga S; Hiroishi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):320-6. PubMed ID: 1694212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
    Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS; Morgan AC
    Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
    Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
    Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mechanism of cytotoxicity of monoclonal antibodies to gynecological cancer cell-lines].
    Iida S; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Jul; 42(7):667-74. PubMed ID: 2212803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
    Macor P; Mezzanzanica D; Cossetti C; Alberti P; Figini M; Canevari S; Tedesco F
    Cancer Res; 2006 Apr; 66(7):3876-83. PubMed ID: 16585216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of human IgA antibodies on complement-dependent cytotoxicity mediated by combinations of EGF-R-directed antibodies.
    Lohse S; Peipp M; Beyer T; Valerius T; Dechant M
    Arch Immunol Ther Exp (Warsz); 2010 Aug; 58(4):303-12. PubMed ID: 20508996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody dependent cellular cytotoxicity and complement mediated cytotoxicity on leukemic cells mediated by anti K562 monoclonal antibodies.
    Tatake RJ; Maniar HS; Chiplunkar SV; Somasundaram R; Amin MK; Saikia T; Gangal SG
    J Clin Lab Immunol; 1990 Feb; 31(2):87-91. PubMed ID: 1966990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are human anti-idiotypic anti-OC125 antibodies formed after immunization with the anti-CA125 antibody B43.13?
    Reinsberg J; Krebs D
    Hybridoma; 1997 Feb; 16(1):59-63. PubMed ID: 9085130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
    Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
    Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo antitumor effects of murine monoclonal antibody NCC-ST-421 reacting with dimeric Le(a) (Le(a)/Le(a)) epitope.
    Watanabe M; Ohishi T; Kuzuoka M; Nudelman ED; Stroud MR; Kubota T; Kodairo S; Abe O; Hirohashi S; Shimosato Y
    Cancer Res; 1991 Apr; 51(8):2199-204. PubMed ID: 1706961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple reactivities of cytotoxic monoclonal antibodies against pancreatic islet cells.
    Suzuki M; Sharma B; Waldeck N; Charles MA
    Diabetes Res; 1984 Nov; 1(4):179-81. PubMed ID: 6397292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity.
    van Meerten T; van Rijn RS; Hol S; Hagenbeek A; Ebeling SB
    Clin Cancer Res; 2006 Jul; 12(13):4027-35. PubMed ID: 16818702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells.
    Xu FJ; Yu YH; Li BY; Moradi M; Elg S; Lane C; Carson L; Ramakrishnan S
    Cancer Res; 1991 Aug; 51(15):4012-9. PubMed ID: 1855217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterogeneity of the CA125 antigen that coexpresses sialyl Tn and CA19-9 antigens].
    Kobayashi H; Ohi H; Shinohara H; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):980-6. PubMed ID: 8371024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H; Moroyama T; Mendelsohn J
    Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.